Association of anandamide with altered binocular depth inversion illusion in schizophrenia

An Introduction to the Endogenous Cannabinoid System

(2016) Hui-Chen Lu et al.   BIOLOGICAL PSYCHIATRY

The cannabinoid system and visual processing: A review on experimental findings and clinical presumptions

(2015) Thomas Schwitzer et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia

(2014) Helena Fatouros-Bergman et al.   SCHIZOPHRENIA RESEARCH

Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia

(2013) Jenny Ceccarini et al.   NEUROIMAGE

The global cognitive impairment in schizophrenia: Consistent over decades and around the world

(2013) Jonathan Schaefer et al.   SCHIZOPHRENIA RESEARCH

The Endocannabinoid System and the Brain

(2012) Raphael Mechoulam et al.   Annual Review of Psychology

Anandamide Dysfunction in Prodromal and Established Psychosis

(2012) F. Markus Leweke   CURRENT PHARMACEUTICAL DESIGN

Rethinking schizophrenia

(2010) Thomas R. Insel   NATURE

Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR

(2010) Dean F. Wong et al.   NEUROIMAGE

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

(2009) Dagmar Koethe et al.   BRITISH JOURNAL OF PSYCHIATRY

Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia

(2009) Dagmar Koethe et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Understanding why patients with schizophrenia do not perceive the hollow-mask illusion using dynamic causal modelling

(2009) Danai Dima et al.   NEUROIMAGE

Visual Perception and Its Impairment in Schizophrenia

(2008) Pamela D. Butler et al.   BIOLOGICAL PSYCHIATRY